Jason Miller @JasonMillerinDC
“Even Pfizer, which did not take direct investment from Operation Warp Speed, benefited from having a $2bn pre-order for when its vaccine gets approved, said Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering.” https://t.co/NLy8NFxhjf — PolitiTweet.org